| Molecular interactions in posaconazole amorphous solid dispersions from two-dimensional solid-state NMR spectroscopy X Lu, C Huang, MB Lowinger, F Yang, W Xu, CD Brown, D Hesk, ... Molecular pharmaceutics 16 (6), 2579-2589, 2019 | 75 | 2019 |
| Sustained release drug delivery applications of polyurethanes MB Lowinger, SE Barrett, F Zhang, RO Williams III Pharmaceutics 10 (2), 55, 2018 | 67 | 2018 |
| Multifunctional protein-encapsulated polycaprolactone scaffolds: fabrication and in vitro assessment for tissue engineering S Ozkan, DM Kalyon, X Yu, CA McKelvey, M Lowinger Biomaterials 30 (26), 4336-4347, 2009 | 62 | 2009 |
| A comparison of the crystallization inhibition properties of bile salts N Li, LI Mosquera-Giraldo, CH Borca, JD Ormes, M Lowinger, JD Higgins, ... Crystal Growth & Design 16 (12), 7286-7300, 2016 | 57 | 2016 |
| Influence of mechanical and thermal energy on nifedipine amorphous solid dispersions prepared by hot melt extrusion: Preparation and physical stability X Ma, S Huang, MB Lowinger, X Liu, X Lu, Y Su, RO Williams III International journal of pharmaceutics 561, 324-334, 2019 | 55 | 2019 |
| Achieving a Hot Melt Extrusion Design Space for the Production of Solid Solutions L Schenck, G Troup, M Lowinger, L Li, C McKelvey Chemical Engineering in the Pharmaceutical Industry: R&D to Manufacturing …, 2010 | 49* | 2010 |
| Maintaining supersaturation of active pharmaceutical ingredient solutions with biologically relevant bile salts J Lu, JD Ormes, M Lowinger, AKP Mann, W Xu, JD Litster, LS Taylor Crystal Growth & Design 17 (5), 2782-2791, 2017 | 39 | 2017 |
| Impact of endogenous bile salts on the thermodynamics of supersaturated active pharmaceutical ingredient solutions J Lu, JD Ormes, M Lowinger, W Xu, A Mitra, AKP Mann, JD Litster, ... Crystal Growth & Design 17 (3), 1264-1275, 2017 | 36 | 2017 |
| Hot-melt extrusion for solid dispersions: composition and design considerations C Brown, J DiNunzio, M Eglesia, S Forster, M Lamm, M Lowinger, ... Amorphous solid dispersions: theory and practice, 197-230, 2014 | 35 | 2014 |
| Atomic-level drug substance and polymer interaction in posaconazole amorphous solid dispersion from solid-state NMR X Lu, M Li, C Huang, MB Lowinger, W Xu, L Yu, SR Byrn, AC Templeton, ... Molecular pharmaceutics 17 (7), 2585-2598, 2020 | 33 | 2020 |
| Drug eluting implants in pharmaceutical development and clinical practice AR Johnson, SP Forster, D White, G Terife, M Lowinger, RS Teller, ... Expert Opinion on Drug Delivery 18 (5), 577-593, 2021 | 32 | 2021 |
| Impact of bile salts on solution crystal growth rate and residual supersaturation of an active pharmaceutical ingredient J Lu, JD Ormes, M Lowinger, AKP Mann, W Xu, S Patel, JD Litster, ... Crystal Growth & Design 17 (6), 3528-3537, 2017 | 32 | 2017 |
| In Vitro and In Vivo Behaviors of KinetiSol and Spray-Dried Amorphous Solid Dispersions of a Weakly Basic Drug and Ionic Polymer† SV Jermain, MB Lowinger, DJ Ellenberger, DA Miller, Y Su, ... Molecular Pharmaceutics 17 (8), 2789-2808, 2020 | 28 | 2020 |
| Influence of carbamazepine dihydrate on the preparation of amorphous solid dispersions by hot melt extrusion X Ma, F Müller, S Huang, M Lowinger, X Liu, R Schooler, RO Williams III Pharmaceutics 12 (4), 379, 2020 | 23 | 2020 |
| Discovering and developing molecules with optimal drug-like properties AC Templeton, SR Byrn, RJ Haskell, TE Prisinzano Springer New York, 2015 | 21 | 2015 |
| Practical considerations for spray dried formulation and process development M Lowinger, J Baumann, DT Vodak, J Moser Discovering and developing molecules with optimal drug-like properties, 383-435, 2014 | 19 | 2014 |
| Compositional effect of complex biorelevant media on the crystallization kinetics of an active pharmaceutical ingredient J Lu, JD Ormes, M Lowinger, AKP Mann, W Xu, S Patel, JD Litster, ... CrystEngComm 19 (32), 4797-4806, 2017 | 18 | 2017 |
| Can drug release rate from implants be tailored using poly (urethane) mixtures? MB Lowinger, Y Su, X Lu, RO Williams III, F Zhang International Journal of Pharmaceutics 557, 390-401, 2019 | 17 | 2019 |
| Polymer formulations of CETP inhibitors S Geers, M Lowinger, CA Mckelvey, RF Meyer, D Zhang US Patent 8,030,359, 2011 | 17 | 2011 |
| HME for solid dispersions: scale-up and late-stage development C Brown, J DiNunzio, M Eglesia, S Forster, M Lamm, M Lowinger, ... Amorphous Solid Dispersions: Theory and Practice, 231-260, 2014 | 13 | 2014 |
